Compumedics (ASX:CMP) said earnings before interest, taxes, depreciation and amortization (EBITDA) rose 72% to AU$5.4 million in fiscal 2026, with EBITDA margin increasing to about 9% and net profit after tax returning to profit at AU$200,000, according to a Tuesday Australian bourse filing.
The company said fiscal 2026 revenue was AU$60.3 million, up nearly 19% on fiscal 2025.
The company's shares rose 2% in recent Tuesday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.